Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

Background The effect of early as compared with later initiation of direct oral anticoagulants
(DOACs) in persons with atrial fibrillation who have had an acute ischemic stroke is unclear …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Recurrent stroke affects 9% to 15% of people within 1 year. This European Stroke
Organisation (ESO) guideline provides evidence-based recommendations on …

Stroke is a leading cause of permanent disability. Therefore, primary prevention of first
stroke and secondary prevention of recurrent stroke are a high priority. Primary prevention of …

Background: There are no evidence-based recommendations on the optimal time point to
initiate non–vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …

Stroke is one of the leading causes of morbidity and mortality worldwide. As the number of
stroke cases is rising from one year to another, policymakers require data on the amount …

Background: There are multiple stroke guidelines globally. To synthesize these and
summarize what existing stroke guidelines recommend about the management of people …

We aimed to provide practical recommendations for the screening of subclinical atrial
fibrillation (AF) in patients with ischaemic stroke or transient ischaemic attack (TIA) of …